Mettler-Toledo International Inc. (NYSE:MTD) Shares Acquired by Royal Bank of Canada

Royal Bank of Canada increased its stake in Mettler-Toledo International Inc. (NYSE:MTD) by 7.3% during the 4th quarter, Holdings Channel.com reports. The fund owned 45,756 shares of the medical instruments supplier’s stock after buying an additional 3,105 shares during the period. Royal Bank of Canada’s holdings in Mettler-Toledo International were worth $55,990,000 at the end of the most recent quarter.

Other hedge funds have also modified their holdings of the company. JPMorgan Chase & Co. boosted its position in shares of Mettler-Toledo International by 14.7% in the third quarter. JPMorgan Chase & Co. now owns 221,799 shares of the medical instruments supplier’s stock worth $332,634,000 after acquiring an additional 28,478 shares during the last quarter. Allworth Financial LP boosted its position in shares of Mettler-Toledo International by 367.4% in the fourth quarter. Allworth Financial LP now owns 215 shares of the medical instruments supplier’s stock worth $285,000 after acquiring an additional 169 shares during the last quarter. Robeco Institutional Asset Management B.V. boosted its position in shares of Mettler-Toledo International by 18.0% in the fourth quarter. Robeco Institutional Asset Management B.V. now owns 34,370 shares of the medical instruments supplier’s stock worth $42,058,000 after acquiring an additional 5,234 shares during the last quarter. Tokio Marine Asset Management Co. Ltd. boosted its position in shares of Mettler-Toledo International by 773.3% in the fourth quarter. Tokio Marine Asset Management Co. Ltd. now owns 5,336 shares of the medical instruments supplier’s stock worth $6,530,000 after acquiring an additional 4,725 shares during the last quarter. Finally, Impax Asset Management Group plc boosted its position in shares of Mettler-Toledo International by 5.8% in the fourth quarter. Impax Asset Management Group plc now owns 198,852 shares of the medical instruments supplier’s stock worth $243,331,000 after acquiring an additional 10,830 shares during the last quarter. 95.07% of the stock is owned by institutional investors and hedge funds.

Insider Transactions at Mettler-Toledo International

In other news, insider Christian Magloth sold 790 shares of the business’s stock in a transaction on Monday, February 24th. The shares were sold at an average price of $1,313.69, for a total transaction of $1,037,815.10. Following the transaction, the insider now directly owns 734 shares of the company’s stock, valued at approximately $964,248.46. The trade was a 51.84% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Corporate insiders own 0.77% of the company’s stock.

Mettler-Toledo International Stock Up 2.3%

Shares of MTD stock opened at $1,185.46 on Wednesday. The firm’s 50 day moving average price is $1,105.55 and its two-hundred day moving average price is $1,216.11. Mettler-Toledo International Inc. has a fifty-two week low of $946.69 and a fifty-two week high of $1,546.93. The stock has a market cap of $24.64 billion, a price-to-earnings ratio of 29.25, a price-to-earnings-growth ratio of 3.30 and a beta of 1.40.

Mettler-Toledo International (NYSE:MTD) last posted its earnings results on Thursday, May 1st. The medical instruments supplier reported $8.19 EPS for the quarter, topping analysts’ consensus estimates of $7.90 by $0.29. Mettler-Toledo International had a net margin of 22.29% and a negative return on equity of 591.54%. The business had revenue of $883.74 million for the quarter, compared to analysts’ expectations of $876.61 million. During the same period in the previous year, the company posted $8.89 earnings per share. The business’s revenue for the quarter was down 4.6% compared to the same quarter last year. On average, equities analysts forecast that Mettler-Toledo International Inc. will post 42.71 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

Several research firms recently issued reports on MTD. StockNews.com cut shares of Mettler-Toledo International from a “buy” rating to a “hold” rating in a research report on Monday, May 5th. Robert W. Baird decreased their target price on shares of Mettler-Toledo International from $1,369.00 to $1,034.00 and set a “neutral” rating on the stock in a research report on Tuesday, April 22nd. Citigroup raised shares of Mettler-Toledo International from a “neutral” rating to a “buy” rating and set a $1,400.00 price target on the stock in a research report on Monday, April 7th. Evercore ISI lifted their price target on shares of Mettler-Toledo International from $1,450.00 to $1,475.00 and gave the company an “outperform” rating in a research report on Monday, February 10th. Finally, UBS Group raised shares of Mettler-Toledo International from a “neutral” rating to a “buy” rating and reduced their price target for the company from $1,530.00 to $1,350.00 in a research report on Tuesday. Seven research analysts have rated the stock with a hold rating and four have assigned a buy rating to the stock. According to MarketBeat, Mettler-Toledo International currently has a consensus rating of “Hold” and an average price target of $1,302.11.

Mettler-Toledo International Company Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.